대한족부족관절학회지 (Journal of Korean Foot and Ankle Society)

  • 제17권4호
  • /
  • Pages.277-282
  • /
  • 2013
  • /
  • 1738-3757(pISSN)
  • /
  • 2288-8551(eISSN)
대한족부족관절학회 (Korean Foot & Ankle Society)
권호 표지

족부의 만성 궤양성 병변에서 nanocrystalline silver 제제 ($Acticoat^{TM}$)를 이용한 자가치료의 효용성

The Effectiveness of Home Treatment with Nanocrystalline Silver Product ($Acticoat^{TM}$) on the Chronic Ulcerative Lesion of Foot

  • 채승범 (대구가톨릭대학교 의과대학 정형외과학교실) ;
  • 정석환 (대구가톨릭대학교 의과대학 정형외과학교실) ;
  • 이상욱 (대구가톨릭대학교 의과대학 정형외과학교실)
  • Chae, Seung-Bum (Department of Orthopaedic Surgery, Daegu Catholic University College of Medicine) ;
  • Jung, Suk-Han (Department of Orthopaedic Surgery, Daegu Catholic University College of Medicine) ;
  • Lee, Sang-Wook (Department of Orthopaedic Surgery, Daegu Catholic University College of Medicine)
  • 투고 : 2013.10.18
  • 심사 : 2013.11.12
  • 발행 : 2013.12.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: This study was performed to evaluate the effectiveness of self-home dressing with nanocrystalline silver dressing method on the treatment of chronic ulcer wounds of the foot. Material and Methods: One hundred-nine patients with chronic foot ulcer due to various causes were treated with nanocrystalline silver dressing material. Dressing was done by themselves in their home. Dressing changes were performed every 2 to 3 days until complete reepithelization. Results: One hundred two cases of all cases had a complete reepithelization. It took 49 days to have a complete reepithelization on average. Seven cases failed to complete reepithelization because of infection. There was no silver intoxication in any cases. Conclusion: Using nanocrystalline silver is a useful dressing method for various superficial chronic ulcer and it can be done by themselves at their home. Thus it is considered to be more comfortable to both patients and doctors.

키워드

참고문헌

  1. Wright B, Lam K., Buret A. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen. 2002;10:141-51. https://doi.org/10.1046/j.1524-475X.2002.10308.x
  2. Fong J, Wood F, Fowler B. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: Comparative patient care audits. Burns. 2005;31(5):562-7. https://doi.org/10.1016/j.burns.2004.12.009
  3. Dunn K, Edwards-Jones V. The role of $Acticoat^{TM}$ with nanocrystalline silver in the management of burns. Burns. 2004;30(Supp 1):S1-9. https://doi.org/10.1016/S0305-4179(04)90000-9
  4. Arican M et al. Effect of Acticoat(R) and Cutinova Hydro (R) on wound healing. Int Wound J.2013;10(5);549-54. https://doi.org/10.1111/j.1742-481X.2012.01021.x
  5. Marija Trop et al. Silver-Coated Dressing Acticoat Caused Raised Liver Enzymes and Argyria-like Symptoms in Burm Patient. The journal of TRAUMA injury, Infection, and Critical Care. 2006;60:648-53. https://doi.org/10.1097/01.ta.0000208126.22089.b6
  6. Fraser J, Kemp M et al. Cytoxicity of topical antimicrobial agents used in burn wounds in Australasia. ANZ J Surg. 2004;74:139-42. https://doi.org/10.1046/j.1445-2197.2004.02916.x
  7. Poon VK, Burd A. In vitro cytotoxicity of silver: implication for clinical wound care. Burns. 2004;30(2):140-7. https://doi.org/10.1016/j.burns.2003.09.030
  8. Coombs CJ et al. Do burn patients have a silver lining? Burns. 1992;18:179-84. https://doi.org/10.1016/0305-4179(92)90067-5
  9. WRight B, Burrell RE. The comparative efficacy of two antimicrobial barrier dressings. wounds. 1998;10:179-88.
  10. Boonkaew, B et al. Antimicrobial efficacy of a novel silver hydrogel dressing compared to two common silver burn wound dressings: Acticoat and PolyMem Silver. Burns. 2013
  11. Huang Y et al. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns. 2007;33(2):161-6. https://doi.org/10.1016/j.burns.2006.06.020
  12. R, K. Matrix metalloproteinases in normal and impaired wound healing:A potential role of nanocrystalline silver. wounds. 2002;13:4-10.
  13. Voight D et al. The use of Acticoat as silver impregnated Telfa dressings in a Resional burn and wound care center :the clinicians view. wounds. 2001;13:11-23.
  14. Fong J. The use of silver products in the management of burn wounds: change in preactice for the burn unit at Royal Perth Hospital Primary intention 2005;13:S16-6.
  15. Fong J, Wood F. Nanocrystalline silver dressings in wound management: a review. Int J Nanomedicine. 2006;1(4):441-50. https://doi.org/10.2147/nano.2006.1.4.441
  16. A.B.G. Lansdown. Silver 1: its antibacterial properties and mechanism of action J Wound Care. 2002;11:125-38. https://doi.org/10.12968/jowc.2002.11.4.26389
  17. Demling R, et al. The role of silver technology in wound healing: Part 1:Effects of silver on wound management. wounds. 2001;13:4-11.
  18. Innes M et al. The use of silver coated dressings on donor site wounds: a prospectice, controlled matched pair study. Burns. 2001;27:621-7. https://doi.org/10.1016/S0305-4179(01)00015-8
  19. Rustogi R et al. The use of Acticoat in neonatal burns. Burns. 2005;31:878-82. https://doi.org/10.1016/j.burns.2005.04.030
  20. Sibbald R et al. Open label pilot study of prolonged release nanocrystalline silver dressing (Acticoat 7) in the treatment of chronic venous leg ulcers. Wound Repair Regen. 2005;13:35.
  21. Sibbald R et al. The selective anti-inflammatory activity of prolonged release nanocrystalline silver dressing (Acticoat 7) in the treatment of chronic venous leg ulcers. Wound Repair Regen. 2005;13:40.
  22. Tredget E et al. A matched-pair,randomised study evaluationg the efficacy and safety of Acticoat silver-coated dressing for the tratment of burn wounds. J Burn Care Rehabil. 1998;19:531-7. https://doi.org/10.1097/00004630-199811000-00013
  23. Varas R et al. A prospective, randomized trial of Actocoat versus silver sulfadiazine in the treatment of partial thickness burn: which method is less pain? J Burn Care Rehabil. 2005; 26:344-51. https://doi.org/10.1097/01.BCR.0000170119.87879.CA
  24. Limova M et al. Controlled, randomized clinical trial of two hydrocolloid dressings in the management of venous insufficiency ulcers. J Vasc Nurs. 2002;20:22-32. https://doi.org/10.1067/mvn.2002.121907
  25. Stacey MC et al. The influence of dressings on venous ulcer healing-a randonmized trial EUR J Vasc Endovasc Surg. 1997;13:174-9. https://doi.org/10.1016/S1078-5884(97)80015-9
  26. DaCosta RM, Aniceto C, Mendes M. Randomized, doubleblind, placebo-controlled, dose-ranging study of granulocyte macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Repair Regen. 1999;7:17-25. https://doi.org/10.1046/j.1524-475X.1999.00017.x
  27. Falanga V et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol. 1998;134:293-300. https://doi.org/10.1001/archderm.134.3.293
  28. Mostow EN et al. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg. 2005;41:837-43. https://doi.org/10.1016/j.jvs.2005.01.042